Enteric microbiome metabolites correlate with response to simvastatin treatment.
Although statins are widely prescribed medications, there remains considerable variability in therapeutic response. Genetics can explain only part of this variability. Metabolomics is a global biochemical approach that provides powerful tools for mapping pathways implicated in disease and in respons...
Main Authors: | Rima Kaddurah-Daouk, Rebecca A Baillie, Hongjie Zhu, Zhao-Bang Zeng, Michelle M Wiest, Uyen Thao Nguyen, Katie Wojnoonski, Steven M Watkins, Miles Trupp, Ronald M Krauss |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22022402/?tool=EBI |
Similar Items
-
Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment.
by: Rima Kaddurah-Daouk, et al.
Published: (2013-01-01) -
Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment.
by: Miles Trupp, et al.
Published: (2012-01-01) -
Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Published: (2013-01-01) -
Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
by: Siamak MahmoudianDehkordi, et al.
Published: (2022-07-01) -
Metabolic profiling of patients with schizophrenia.
by: Rima Kaddurah-Daouk
Published: (2006-08-01)